From: Changes in fibrinogen availability and utilization in an animal model of traumatic coagulopathy
Base line | 0 minutes | 30 minutes | 60 minutes | ||
---|---|---|---|---|---|
Hgb | TS | 10.67 (0.57) | 9.95 (0.96)* | 9.15 (1.32)* | 8.98 (1.26)* |
T | 10.65 (1.08) | 9.75 (0.72) | 9.58 (0.81)* | 9.53 (0.46) | |
S | 10.35 (0.66) | 8.83 (0.26)* | 8.65 (0.41)* | ||
C | 11.0 (0.35) | 11.05 (0.35) | 10.90 (0.14) | ||
Plt | TS | 619.5 (149.7) | 636.0 (175.1) | 549.5 (119.1)* | 554.7 (146.3)* |
T | 431.8 (110.9) | 482.5 (144.5) | 436.1 (76.6) | 470.0 (98.6) | |
S | 568.0 (74.7) | 570.5 (29.1) | 589.3 (36.2) | ||
C | 539.0 (241.8) | 550.0 2410.4) | 624.5 (334.5) | ||
Fib | TS | 2.24 (0.73) | 2.07 (0.67)* | 1.76 (0.29) | 1.73 (0.29)* |
T | 1.7 (0.07) | 1.66 (0.10) | 1.57 (0.11) | 1.54 (0.11) | |
S | 2.48 (0.62) | 1.93 (0.45)* | 1.98 (0.5)* | ||
C | 2.01 (0.04) | 2.13 (0.06) | 1.92 (0.07) | ||
INR | TS | 0.96 (0.05) | 0.94 (0.05)* | 0.97 (0.06) | 0.98 (0.06) |
T | 0.99 (0.03) | 0.97 (0.03) | 0.98 (0.03) | 0.98 (0.02) | |
S | 0.98 (0.02 | 1.03 (0.01)* | 1.04 (0.03)* | ||
C | 0.98 (0.01) | 0.98 (0.01) | 1.00 (0.02) | ||
aPTT | TS | 19.2 (1.35) | 18.7 (1.14)* | 19.1 (1.11) | 19.5 (1.55) |
T | 19.5 (1.38) | 19.0 (1.37) | 19.1 (1.72) | 19.3 (1.05) | |
S | 22.3 (0.92) | 21.9 (2.84) | 22.7 (3.17) | ||
C | 21.5 (0.92) | 21.3 (0.28) | 22.2 (0.64) |